![Gudarz Davar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Gudarz Davar is Executive VP, Head-Research & Development at ACADIA Pharmaceuticals, Inc. In his past career Dr. Davar was VP & Head-Global Neurology Clinical Development at Eli Lilly & Co. He received a doctorate from Dalhousie University.
Former positions of Gudarz Davar
| Companies | Position | End |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2020-07-31 |
| ACADIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | - |
Training of Gudarz Davar
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
20
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Dalhousie University
 Dalhousie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Gudarz Davar
